{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:58:11Z","timestamp":1794013091283,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.amjmed.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T12:38:15Z","timestamp":1552739895000},"page":"802-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":767,"title":["Parkinson's Disease and Parkinsonism"],"prefix":"10.1016","volume":"132","author":[{"given":"Michael T.","family":"Hayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2019.03.001_bb0005","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","article-title":"Parkinson\u2019s disease from pathology to molecular disease mechanisms","volume":"62","author":"Dexter","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0010","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","article-title":"Gender differences in Parkinson\u2019s disease","volume":"78","author":"Haaxma","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.amjmed.2019.03.001_bb0015","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s disease: variations by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.amjmed.2019.03.001_bb0020","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1212\/WNL.42.7.1328","article-title":"Parkinson\u2019s disease and exposure to agricultural work and pesticide chemicals","volume":"42","author":"Semchuk","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.10277","article-title":"A meta-analysis of coffee drinking, cigarette smoking and the risk of Parkinson\u2019s disease","volume":"52","author":"Hernan","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.amjmed.2019.03.001_bb0035","first-page":"213","article-title":"Lapeyre-Mestre et al. A study of salivary secretion in Parkinson\u2019s disease","volume":"22","author":"Bagheri","year":"1999","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"10.1016\/j.amjmed.2019.03.001_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.14802\/jmd.15018","article-title":"What is wrong with balance in Parkinson\u2019s disease?","volume":"8","author":"Parks","year":"2015","journal-title":"J Mov Disord"},{"issue":"7","key":"10.1016\/j.amjmed.2019.03.001_bb0045","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.parkreldis.2008.12.005","article-title":"The prevalence of smell loss in Parkinson\u2019s disease \u2013 a multicenter study","volume":"15","author":"Haehne","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"issue":"suppl 3","key":"10.1016\/j.amjmed.2019.03.001_bb0050","first-page":"III30","article-title":"Environmental, life style and physical precursors of clinical Parkinson\u2019s disease: recent findings of the Honolulu-Asia aging study","volume":"250","author":"Abbott","year":"2003","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.amjmed.2019.03.001_bb0055","first-page":"490","article-title":"Excess burden of constipation in Parkinson\u2019s Disease: a pilot study","volume":"15","author":"Kaye","year":"2001","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0060","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mds.1203","article-title":"Gastric emptying and gastric motility in patients with Parkinson\u2019s disease","volume":"16","author":"Hardoff","year":"2001","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.amjmed.2019.03.001_bb0065","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/jnnp.63.5.584","article-title":"Prevalence of orthostatic hypotension in Parkinson\u2019s disease","volume":"63","author":"Senard","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2019.03.001_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0075","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/jnnp.2011.241075","article-title":"Urinary dysfunction in early and untreated Parkinson\u2019s disease","volume":"82","author":"Uchiyama","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"30","key":"10.1016\/j.amjmed.2019.03.001_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systemic review of prevalence studies of depression in Parkinson\u2019s disease","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.parkreldis.2016.12.008","article-title":"Gender effects on non-motor symptoms in Parkinson\u2019s disease: are men more at risk?","volume":"35","author":"Nicoletti","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1016\/j.amjmed.2019.03.001_bb0090","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s00415-017-8638-1","article-title":"The natural history of depressive symptoms in patients with incident Parkinson\u2019s disease: a prospective cohort study","volume":"264","author":"Larsen","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.parkreldis.2016.12.026","article-title":"Gender differences in Parkinson\u2019s disease depression","volume":"36","author":"Perrin","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/jnnp.2010.213652","article-title":"Depression and anxiety related subtypes in Parkinson\u2019s disease","volume":"82","author":"Brown","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2018.08.004","article-title":"\u201cPure apathy\u201d and cognitive dysfunctions in Parkinson\u2019s disease: a meta-analytic study","volume":"94","author":"D\u2019lorio","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"issue":"10","key":"10.1016\/j.amjmed.2019.03.001_bb0110","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.20527","article-title":"A systematic review of prevalence studies of dementia in Parkinson\u2019s disease","volume":"20","author":"Aarslan","year":"2005","journal-title":"Mov Disord"},{"issue":"9","key":"10.1016\/j.amjmed.2019.03.001_bb0115","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mds.20216","article-title":"Risk and incidence of dementia in a cohort of older patients with Parkinson\u2019s disease in the UK","volume":"19","author":"Hobson","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.parkreldis.2016.02.024","article-title":"Dementia in Parkinson\u2019s disease: is male gender a risk factor?","volume":"26","author":"Cereda","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0125","first-page":"25","article-title":"Apoptosis and autophagy in nigral neurons of patients with Parkinson\u2019s disease","volume":"12","author":"Anglade","year":"1997","journal-title":"Histol Histopathol"},{"issue":"6","key":"10.1016\/j.amjmed.2019.03.001_bb0130","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease","volume":"12","author":"Shapira","year":"2011","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.amjmed.2019.03.001_bb0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11910-013-0409-5","article-title":"Parkinson\u2019s disease: current knowledge","volume":"13","author":"Depression","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"16","key":"10.1016\/j.amjmed.2019.03.001_bb0140","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e3182516244","article-title":"A randomized, double blind, placebo-controlled trial of antidepressants in Parkinson\u2019s disease","volume":"78","author":"Richard","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.amjmed.2019.03.001_bb0145","first-page":"433","article-title":"Cognitive behavioral therapy in depression and anxiety in Parkinson\u2019s disease","volume":"5","author":"Egan","year":"2015","journal-title":"J Park Dis"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0150","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1532-5415.1954.tb02479.x","article-title":"Surgical alleviation of Parksinonism: effects of ablation of the anterior choroidal artery","volume":"2","author":"Cooper","year":"1954","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1126\/science.106.2754.349","article-title":"Stereotaxic apparatus for operations on the human brain","volume":"106","author":"Spiegal","year":"1947","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.amjmed.2019.03.001_bb0160","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJMoa000827","article-title":"Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson\u2019s disease","volume":"345","author":"Deep Brain Stimulation for Parkinson\u2019s Disease Study Group","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amjmed.2019.03.001_bb0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1227\/01.NEU.0000307964.21298.FD","article-title":"Exhaustive, one year follow up of subthalamic nucleus deep brain in a large, single center cohort of parkinsonian patients","volume":"61","author":"Tir","year":"2007","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.amjmed.2019.03.001_bb0170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nrneurol.2014.252","article-title":"Axial disability and deep brain stimulation in patients with Parkinson\u2019s disease","volume":"11","author":"Fasano","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0175","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jocn.2017.06.018","article-title":"An investigation into the effects and prognostic factors of cognitive decline following subthalamic nucleus stimulation in patients with Parkinson\u2019s disease","volume":"44","author":"Nimura","year":"2017","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00005072-196104000-00007","article-title":"Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion","volume":"20","author":"Okazaki","year":"1961","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10.1016\/j.amjmed.2019.03.001_bb0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00314594","article-title":"Diffuse Lewy body disease in Japan","volume":"237","author":"Kosaka","year":"1990","journal-title":"J Neurol"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0190","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bmj.305.6855.673","article-title":"Neuroleptic sensitivity in patients with senile dementia of Lewy Body type","volume":"305","author":"McKeith","year":"1992","journal-title":"BMJ"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2019.03.001_bb0195","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00002826-198300061-00004","article-title":"Neuroleptic induced extrapyramidal reaction: classification, description ad diagnosis","volume":"6","author":"Tarsy","year":"1983","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0200","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2036.2004.01867.x","article-title":"Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics","volume":"19","author":"Tonini","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.amjmed.2019.03.001_bb0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/mds.24000","article-title":"Dopamine transporter imaging in autopsy-confirmed Parksinon\u2019s disease and multiple system atrophy","volume":"27","author":"Perju-Dumbrava","year":"2012","journal-title":"Mov Disord"},{"issue":"suppl","key":"10.1016\/j.amjmed.2019.03.001_bb0210","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/mds.10573","article-title":"Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice","volume":"7","author":"Poewe","year":"2003","journal-title":"Mov Disord"},{"issue":"suppl","key":"10.1016\/j.amjmed.2019.03.001_bb0215","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1002\/mds.10575","article-title":"Gallardo M. DAT imaging in drug induced and psychogenic parkinsonism","volume":"7","author":"Tolosa","year":"2003","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.amjmed.2019.03.001_bb0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00023210-200216010-00003","article-title":"Effects of newer antipsychotics on extrapyramidal function","volume":"16","author":"Tarsy","year":"2002","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.amjmed.2019.03.001_bb0225","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.21116","article-title":"Effect of quetiapine in psychotic Parkinson\u2019s disease patients: a double blind labeled study of 3 months duration","volume":"22","author":"Rabey","year":"2007","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.amjmed.2019.03.001_bb0230","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","article-title":"Neuropathology of variants of progressive supranuclear palsy","volume":"23","author":"Dickson","year":"2010","journal-title":"Curr Opin Neurol"},{"issue":"12","key":"10.1016\/j.amjmed.2019.03.001_bb0235","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2165\/00002512-200118120-00003","article-title":"Progressive supranuclear palsy: clinical features, pathophysiology and management","volume":"18","author":"Rajput","year":"2001","journal-title":"Drugs Aging"},{"issue":"15","key":"10.1016\/j.amjmed.2019.03.001_bb0240","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/mds.21698","article-title":"Pure akinesia with gait freezing: a third phenotype of progressive supranuclear palsy","volume":"22","author":"Williams","year":"2007","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.amjmed.2019.03.001_bb0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","article-title":"Progressive supranuclear palsy: pathology and genetics","volume":"17","author":"Dickson","year":"2007","journal-title":"Brain Pathol"},{"issue":"4","key":"10.1016\/j.amjmed.2019.03.001_bb0250","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(12)70022-4","article-title":"Premotor signs and symptoms of multiple system atrophy","volume":"11","author":"Jecmenica-Lukic","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0255","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/brain\/117.4.835","article-title":"Clinical features and natural history of multiple system atrophy: an analysis of 100 cases","volume":"117","author":"Wenning","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0265","first-page":"183","article-title":"Phenotypes and prognosis: clinicopathologic studies of corticobasal degeneration","volume":"82","author":"Litvan","year":"2000","journal-title":"Adv Neurol"},{"key":"10.1016\/j.amjmed.2019.03.001_bb0270","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00019052-199908000-00011","article-title":"Recent advances in atypical parkinsonian disorders","volume":"12","author":"Litvan","year":"1999","journal-title":"Curr Opin Neurol"},{"issue":"suppl 2","key":"10.1016\/j.amjmed.2019.03.001_bb0275","doi-asserted-by":"crossref","first-page":"II6","DOI":"10.1007\/BF03161076","article-title":"Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration","volume":"246","author":"Dickson","year":"1999","journal-title":"J Neurol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319302359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319302359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:17:41Z","timestamp":1757582261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934319302359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0002934319302359"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2019.03.001","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson's Disease and Parkinsonism","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}